Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-03-09 AGM Information
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by Seegene to explain why their Annual General Meeting (AGM) is being held on a 'concentrated' date (a date when many other companies are also holding their AGMs). It is a specific regulatory disclosure required by the KOSDAQ association regarding shareholder meeting scheduling. Since it does not contain the actual meeting materials, proxy statements, or voting results, but rather serves as a regulatory notification of scheduling, it falls under the general regulatory filing category.
2021-03-09 Korean
[기재정정]회계처리기준위반에따른임원의해임권고조치
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing regarding accounting violations, specifically detailing sanctions imposed by the Securities and Futures Commission (SFC) on the company (Seegene). It outlines specific accounting errors (revenue overstatement, debt classification, development cost capitalization) and the resulting penalties (fines, auditor designation, and management dismissal recommendations). This falls under regulatory actions and legal/compliance matters, making 'LTR' (Legal Proceedings Report) the most accurate classification for reporting on regulatory sanctions and legal/compliance outcomes.
2021-03-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership for an executive (Choi Jin-su) of Seegene due to his resignation. This type of filing, which reports personal share transactions or changes in status by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2021-02-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details the share ownership, changes in holdings, and major contracts (such as collateral agreements) of the company's largest shareholder and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2021-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Disclosure of Significant Changes in Sales or Profit/Loss' (매출액 또는 손익구조 30% 이상 변동). This is a standard preliminary earnings announcement required by Korean regulations when there is a significant variance in financial performance compared to the previous year. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change. Since it is an initial announcement of financial results rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2020
2021-02-18 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (연결재무제표 기준 영업(잠정)실적) from Seegene. It provides key financial highlights (revenue, operating profit, net income) for the 4th quarter of 2020. It explicitly states that these are preliminary figures (잠정치) and not the final audited report. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results. Q4 2020
2021-02-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.